Ronald Crys­tal's Lex­eo Ther­a­peu­tics pulls in a $100M megaround just nine months af­ter launch

About a month af­ter Lex­eo Ther­a­peu­tics ac­quired Ste­lios Ther­a­peu­tics — bring­ing its 18-pro­gram gene ther­a­py pipeline to 21 — in­vestors are reach­ing a lit­tle deep­er in­to their …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER